Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) have been given a consensus broker rating score of 2.00 (Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and one has issued a strong buy rating on the company.
Zacks has also given Innophos an industry rank of 35 out of 265 based on the ratings given to its competitors.
A number of research firms have recently commented on IPHS. Zacks Investment Research downgraded Innophos from a “buy” rating to a “hold” rating in a report on Wednesday. KeyCorp restated a “hold” rating on shares of Innophos in a report on Wednesday, November 1st. Finally, BidaskClub upgraded Innophos from a “hold” rating to a “buy” rating in a report on Friday, December 22nd.
Innophos (NASDAQ:IPHS) last released its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. The company had revenue of $184.00 million for the quarter, compared to the consensus estimate of $179.33 million. Innophos had a return on equity of 13.90% and a net margin of 6.19%. The company’s quarterly revenue was down 1.1% compared to the same quarter last year. During the same period last year, the business posted $0.69 EPS. analysts predict that Innophos will post 2.5 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th were issued a $0.48 dividend. The ex-dividend date of this dividend was Thursday, November 16th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.06%. Innophos’s dividend payout ratio (DPR) is 88.48%.
Several institutional investors have recently added to or reduced their stakes in IPHS. Old Mutual Global Investors UK Ltd. purchased a new position in shares of Innophos in the 3rd quarter worth about $109,000. Public Employees Retirement System of Ohio raised its holdings in shares of Innophos by 5.9% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after buying an additional 157 shares during the period. Macquarie Group Ltd. purchased a new stake in shares of Innophos during the 3rd quarter valued at about $193,000. Piedmont Investment Advisors LLC purchased a new stake in shares of Innophos during the 3rd quarter valued at about $209,000. Finally, Pacad Investment Ltd. raised its holdings in shares of Innophos by 19.5% during the 2nd quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock valued at $215,000 after buying an additional 800 shares during the period. Institutional investors own 94.46% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.americanbankingnews.com/2018/01/04/zacks-innophos-holdings-inc-iphs-given-consensus-rating-of-buy-by-analysts.html.
Innophos Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.